Surgical Management of Tumors Involving Meckel's Cave and Cavernous Sinus: Role of an Extended Middle Fossa and Lateral Sphenoidectomy Approach. Issue 1 (January 2018)

• Record Type: Journal Article
• Authors: Sun, Daniel Q.; Menezes, Arnold H.; Howard, Matthew A.; Gantz, Bruce J.; Hasan, David M.; Hansen, Marlan R.
• Is Part Of: Otology & neurotology. Volume 39:Issue 1(2018)
• Publication Date: 2018-01
• Subjects: Cavernous sinus -- Greater sphenoid wing -- Lateral sphenoidectomy -- Meckel's cave -- Meningioma -- Middle fossa -- Schwannoma; Otology -- Periodicals; Ear -- Diseases -- Periodicals; Skull base -- Surgery -- Periodicals; 617.8005
• DOI: 10.1097/MAO.0000000000001602
• Languages: English
• ISSNs: 1531-7129

Abstract

Abstract : Objective: To study the indications and outcomes of lateral sphenoidectomy as part of a combined skull base approach in the treatment of tumors involving Meckel's cave (MC) and cavernous sinus (CS). Study Design: Retrospective patient series. Setting: Tertiary referral center. Patients: Twenty-two consecutive patients (mean age: 45 yr, range: 16–76) who underwent transzygomatic, extended middle fossa approaches for tumors involving MC and CS. Interventions: Surgical access to MC and CS was achieved via extended middle fossa, trans-clinoid approach. Lateral sphenoidectomy was defined as drill-out of the greater sphenoid wing lateral to foramen rotundum and ovale, decompression of superior orbital fissure, and removal of anterior clinoid process. Reconstruction was achieved using combination of autologous and synthetic materials. Eleven patients (50%) received adjuvant radiation. Main Outcome Measures and Results: Tumor pathologies included meningioma (16 patients), epidermoid cyst (2), trigeminal schwannoma (2), invasive pituitary adenoma (1), and chondrosarcoma (1). Mean (range) preoperative tumor size was 4.0 cm (1.3–9). Mean (range) length of follow-up was 4 years (range 0.1–10). Overall tumor control and gross total resection were achieved in 95 and 23% of patients, respectively. Lateral sphenoidectomy was performed in 16 patients (73%) for enhanced surgical access and/or tumor extension to the infratemporal fossa (6 patients). Postoperatively, cranial nerve deficits occurred in 12 (55%) patients (V–9 patients; III, IV, or VI–4; VII–2; VIII–2). Cerebrospinal fluid leak and hydrocephalus occurred in two and four patients, respectively. Conclusion: In combination with middle fossa-based approaches to tumors involving MC and CS, lateral sphenoidectomy may play a viable role in tumor access and control.